97P Neoadjuvant Durvalumab Plus Gemcitabine and Cisplatin (d+gemcis) Versus Gemcis Alone for Localized Biliary Tract Cancer (BTC): Results of a Randomized, Multicenter, Open-Label, Phase II Trial (DEBATE)
ANNALS OF ONCOLOGY(2023)
Key words
Biliary Tract Cancer
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined